...
首页> 外文期刊>Medicine. >Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer
【24h】

Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer

机译:MicroRNA相关基因XPO5 RS11077多态性与甲状腺癌的易感性

获取原文

摘要

Exportin 5 ( XPO5 ) is a microRNA (miRNA)-related nuclear export protein, and its disorder may lead to the dysregulation of miRNAs. Recent studies have demonstrated that the aberrant expression of XPO5 might participate in carcinogenesis in certain cancers. However, there is only limited information of XPO5 in thyroid cancer (TC) development. In our study, we quantified the expression level of XPO5 by real-time polymerase chain reaction (PCR) in 64 TC patients’ cancer tissues and adjacent normal tissues. After confirming the XPO5 expression, we evaluated the association between XPO5 potential functional single-nucleotide polymorphisms (SNPs) and risk of TC in a Chinese population (1140 cases vs 1230 controls). Finally, luciferase assays were performed to investigate the function of the SNP in XPO5 3′ untranslation region. The message ribonucleic acid (RNA) levels of XPO5 were significantly lower in cancer tissues than normal tissues ( P = 0.004). In SNPs screening, only 1 noble SNP rs11077 was identified in XPO5 functional region. The results in our case–control study also confirmed that XPO5 rs11077 was significantly associated with onset of TC (GT/GG vs TT P = 0.035, adjusted odds ratio = 1.25, 95% confidence interval = 1.02–1.54). The adverse influence of this polymorphism was mainly observed in age >45 years ( P = 0.028), female ( P = 0.020), T1 staging ( P = 0.026), N1 ( P = 0.038), metastasis ( P = 0.031 M0, and P = 0.035 for M1), and early stage (I + II) ( P = 0.021). A following luciferase test revealed the critical role of rs11077 for triggering the XPO5 expression. Furthermore, patients with G allele of rs11077 showed lower XPO5 expression level. XPO5 SNP rs11077 influences the expression of XPO5 , and this SNP could also be a potential biomarker for the diagnosis of TC in clinical, especially in Chinese population.
机译:Exportin 5(XPO5)是MicroRNA(miRNA) - 相关的核导出蛋白,其疾病可能导致miRNA的失调。最近的研究表明,XPO5的异常表达可能会在某些癌症中参与致癌作用。然而,在甲状腺癌(TC)发育中只有有限的XPO5信息。在我们的研究中,我们通过实时聚合酶链反应(PCR)在64型TC患者的癌症组织和相邻的正常组织中量化XPO5的表达水平。在确认XPO 5表达后,我们评估了XPO5潜在功能单核苷酸多态性(SNP)之间的关联,以及中国人群中TC的风险(1140例VS 1230控制)。最后,进行荧光素酶测定以研究SNP在XPO5 3'过渡区域中的功能。癌症组织中XPO5的消息核糖核酸(RNA)水平显着低于正常组织(P = 0.004)。在SNPS筛选中,在XPO5功能区域中仅识别了1个高贵的SNP RS11077。在我们的案例对照研究中的结果还证实,XPO5 RS11077与TC发作显着相关(GT / GG VS TT P = 0.035,调整后的差距= 1.25,95%置信区间= 1.02-1.54)。该多态性的不利影响主要在年龄> 45岁(P = 0.028),雌性(P = 0.020),T1分段(P = 0.026),N1(P = 0.038),转移(P = 0.031 M0, M1的P = 0.035),早期(I + II)(P = 0.021)。以下荧光素酶测试显示RS11077触发XPO5表达的关键作用。此外,RS11077的G等位基因患者显示出较低的XPO 5表达水平。 XPO5 SNP RS11077影响XPO5的表达,并且这种SNP也可以是临床诊断TC的潜在生物标志物,特别是在中国人口中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号